Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
43.68 USD | -2.97% | -4.19% | -2.06% |
05-21 | QIAGEN NV : Berenberg maintains a Buy rating | ZD |
05-15 | Qiagen's Updated Clinical Decision Support Platform Secures EU Certification | MT |
Sales 2024 * | 2.01B 2.74B | Sales 2025 * | 2.14B 2.92B | Capitalization | 9.99B 13.65B |
---|---|---|---|---|---|
Net income 2024 * | 404M 552M | Net income 2025 * | 450M 615M | EV / Sales 2024 * | 5.13 x |
Net Debt 2024 * | 314M 429M | Net cash position 2025 * | 193M 264M | EV / Sales 2025 * | 4.58 x |
P/E ratio 2024 * |
24.7
x | P/E ratio 2025 * |
22.2
x | Employees | 5,900 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.86% |
Latest transcript on Qiagen N.V.
1 day | -2.97% | ||
1 week | -4.19% | ||
Current month | +3.59% | ||
1 month | +6.38% | ||
3 months | +0.71% | ||
6 months | +4.64% | ||
Current year | -2.06% |
Managers | Title | Age | Since |
---|---|---|---|
Thierry Bernard
CEO | Chief Executive Officer | 60 | 15-01-31 |
Metin Colpan
FOU | Founder | 69 | 96-04-28 |
Roland Sackers
DFI | Director of Finance/CFO | 56 | 98-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 74 | 11-05-31 | |
Metin Colpan
FOU | Founder | 69 | 96-04-28 |
Lawrence Rosen
CHM | Chairman | 66 | 13-06-25 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
3.10% | 1 M€ | +0.15% | - | |
1.79% | 2 M€ | -.--% | ||
1.65% | 2 M€ | +10.04% | ||
1.32% | 144 M€ | +0.99% | - | |
1.08% | 8 M€ | 0.00% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-22 | 43.84 | -2.62% | 474 088 |
24-05-21 | 45.02 | -0.99% | 773,169 |
24-05-20 | 45.47 | -0.48% | 1,174,719 |
24-05-17 | 45.69 | -0.65% | 1,274,938 |
24-05-16 | 45.99 | +0.48% | 1,078,963 |
Delayed Quote Nyse, May 22, 2024 at 10:38 am
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.06% | 9.99B | |
+56.79% | 55.07B | |
-1.71% | 41.79B | |
+44.47% | 40.22B | |
-7.59% | 28.17B | |
+12.24% | 26.28B | |
-20.90% | 18.93B | |
+7.06% | 13.03B | |
+29.33% | 12.26B | |
+26.17% | 12.21B |
- Stock Market
- Equities
- QGEN Stock